Growth Metrics

Lucid Diagnostics (LUCD) Revenue Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 16.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.08%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 15.05%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 7.41%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.29%
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 57.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 57.00%
Dec 31, 2025 25.65%
Sep 30, 2025 2.39%
Jun 30, 2025 22.95%
Mar 31, 2025 -17.28%
Dec 31, 2024 15.10%
Sep 30, 2024 49.68%
Jun 30, 2024 513.84%
Mar 31, 2024 124.44%
Dec 31, 2023 828.57%
Sep 30, 2023 930.26%
Mar 31, 2023 135.98%
Dec 31, 2022 -62.67%
Sep 30, 2022 -62.00%